Skip to main content

Protein Evolution

Prof. Dr. Rob Russell

We specialize in protein structure and mechanistic data analysis, with a particular focus on genetic variants related to cancer and hereditary diseases.
Our research encompasses all aspects of protein structure, function, and evolution, primarily focusing on molecular interactions such as protein-protein, protein-peptide, and protein-chemical interactions. Over the last decade, our research has been predominantly dedicated to investigating how genetic variants or post-translational modifications affect biomolecular interactions and structure, leading to numerous clinical applications and studies. Our tools, including Mechismo and Mechnetor, enhance structure-based studies of protein alterations. Collaborating globally, we have explored genetic diseases, cancers, and GPCR coupling, resulting in predictive methods and impactful findings. For more information on our research, please visit the Research section. If you are interested in utilizing our online tools, please access the Services section.

Research Strategy

Proteins are the core components of all life processes and thus play central roles in biological mechanism and disease. Over billions of years a seemingly limited repertoire of protein types has evolved to produce an enormous diversity, with some 25 000 distinct proteins in humans and millions throughout nature. Understanding how their evolution is coupled to their function: how they interact with other molecules, form larger molecular machines, and ultimately create the vast complex networks inside of cells is critical for our deeper understanding of how living systems function, or malfunction pathologically. 

 

Our group is primarily interested in deciphering the mechanisms by which proteins recognise other molecules and ultimately to combine these mechanisms into models of molecular machines, pathways and larger biological systems. Central to this is our work on predictive networks, where we use biological networks to predict a variety of biological phenomena from phosphorylation events, to chemical toxicity in humans. We adopt a number of computational methods, coupled to laboratory experiments to deduce mechanism, and are very active in collaborations with other groups in the Heidelberg area, and the rest of the world. We develop and apply bioinformatics methods and numerous databases during the course of our work. We also run a small laboratory where we mostly perform biochemistry and biophysics approaches to test various predictions. Our collaborators include other computational scientists, molecular biologists, structural biologists, proteomics specialists, cell biologists, geneticists, chemists and many others.

Russell
Prof. Dr. Rob Russell

Selected Publications

Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm.

Francesco Raimondi, Asuka Inoue, Francois M. N. Kadji, Ni Shuai, Juan-Carlos Gonzalez, Gurdeep Singh, Alicia Alonso de la Vega, Rocio Sotillo, Bernd Fischer, Junken Aoki, J Silvio Gutkind & Robert B. Russell

Oncogene. 2019 Sep;38(38):6491-6506.


Illuminating G-Protein-Coupling Selectivity of GPCRs.

Asuka Inoue, Francesco Raimondi, Francois Marie Ngako Kadji, Gurdeep Singh, Takayuki Kishi, Akiharu Uwamizu, Yuki Ono, Yuji Shinjo, Satoru Ishida, Nadia Arang, Kouki Kawakami, J. Silvio Gutkind, Junken Aoki & Robert B. Russell

Cell.2019 Jun 13;177(7):1933-1947.e25.


An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

Karsten Boldt, Jeroen van Reeuwijk, Qianhao Lu, Konstantinos Koutroumpas, Thanh-Minh T. Nguyen, Yves Texier, Sylvia E. C. van Beersum, Nicola Horn, Jason R. Willer, Dorus A. Mans, Gerard Dougherty, Ideke J. C. Lamers, Karlien L. M. Coene, Heleen H. Arts, Matthew J. Betts, Tina Beyer, Emine Bolat, Christian Johannes Gloeckner, Khatera Haidari, Lisette Hetterschijt, Daniela Iaconis, Dagan Jenkins, Franziska Klose, Barbara Knapp & UK10K Rare Diseases Group

Nature Communications volume 7, Article number: 11491 (2016)